Below are the most recent publications written about "Fibrin Fibrinogen Degradation Products" by people in Profiles.
-
Caricchio R, Abbate A, Gordeev I, Meng J, Hsue PY, Neogi T, Arduino R, Fomina D, Bogdanov R, Stepanenko T, Ruiz-Seco P, G?nzalez-Garc?a A, Chen Y, Li Y, Whelan S, Noviello S. Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021 07 20; 326(3):230-239.
-
Rali P, O'Corragain O, Oresanya L, Yu D, Sheriff O, Weiss R, Myers C, Desai P, Ali N, Stack A, Bromberg M, Lubitz AL, Panaro J, Bashir R, Lakhter V, Caricchio R, Gupta R, Dass C, Maruti K, Lu X, Rao AK, Cohen G, Criner GJ, Choi ET. Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center. J Vasc Surg Venous Lymphat Disord. 2021 05; 9(3):585-591.e2.
-
Mahan K, Kabrhel C, Goldsmith AJ. Abdominal pain in a patient with COVID-19 infection: A case of multiple thromboemboli. Am J Emerg Med. 2020 Oct; 38(10):2245.e3-2245.e5.
-
Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, Henninger N, Trivedi T, Lillemoe K, Alam S, Sanger M, Kim S, Scher E, Dehkharghani S, Wachs M, Tanweer O, Volpicelli F, Bosworth B, Lord A, Frontera J. SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020 07; 51(7):2002-2011.
-
Frydman GH, Boyer EW, Nazarian RM, Van Cott EM, Piazza G. Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620943671.
-
Akhter M, Kline J, Bhattarai B, Courtney M, Kabrhel C. Ruling out Pulmonary Embolism in Patients with High Pretest Probability. West J Emerg Med. 2018 May; 19(3):487-493.
-
Kearon C, Parpia S, Spencer FA, Baglin T, Stevens SM, Bauer KA, Lentz SR, Kessler CM, Douketis JD, Moll S, Kaatz S, Schulman S, Connors JM, Ginsberg JS, Spadafora L, Bhagirath V, Liaw PC, Weitz JI, Julian JA. Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. Blood. 2018 05 10; 131(19):2151-2160.
-
Goodwin AJ, Higgins RA, Moser KA, Smock KJ, Chandler WL, Kottke-Marchant K, Hartman SK, Volod O, Brown AF, Johari VP, Burr S, Polyakov N, Chen D. Issues Surrounding Age-Adjusted d-Dimer Cutoffs That Practicing Physicians Need to Know When Evaluating Patients With Suspected Pulmonary Embolism. Ann Intern Med. 2017 Mar 07; 166(5):361-363.
-
Tarr GP, Modahl L, Jones P. Wells score, D-dimer testing and computer tomographic pulmonary angiography appropriateness in the Auckland Hospital Adult Emergency Department. N Z Med J. 2015 May 01; 128(1413):81-3.
-
Kearon C, Spencer FA, O'Keeffe D, Parpia S, Schulman S, Baglin T, Stevens SM, Kaatz S, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Moll S, Connors JM, Ginsberg JS, Spadafora L, Julian JA. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med. 2015 Jan 06; 162(1):27-34.